Clinical trials
Recruiting Phase 2 Thrombocythemia, Essential trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 3 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Icahn School of Medicine at Mount Sinai | 1 |
| Massachusetts General Hospital | 1 |
| National Cancer Institute (NCI) | 1 |
| Step Pharma, SAS | 1 |
| Thomas Jefferson University | 1 |
| University of Southern California | 1 |
| University of Washington | 1 |
| Xiamen Amoytop Biotech Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombocythemia, Essential | 8 |
| Polycythemia Vera | 6 |
| Primary Myelofibrosis | 5 |
| Myelodysplastic Syndromes | 3 |
| Leukemia, Myeloid, Acute | 2 |
| Myelodysplastic-Myeloproliferative Diseases | 2 |
| Myeloproliferative Disorders | 2 |
| Anemia, Aplastic | 1 |
| Hodgkin Disease | 1 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.